Urgent.News

What's breaking now, across thousands of outlets.

Editions

Health & Medicine

Ohne Vorwürfe: Kaufsucht: Können Angehörige helfen?

Eine Kaufsucht kann auch für das Umfeld von Betroffenen Folgen haben - psychisch wie finanziell. Viele fühlen sich hilflos. Eine Expertin erklärt, was im Umgang mit Betroffenen entscheidend ist.

Ohne Vorwürfe: Kaufsucht: Können Angehörige helfen?

Hannover - Those affected by compulsive shopping have an intense and sometimes uncontrollable desire to purchase items. This condition affects not only the individual, but also often their family members and close acquaintances. People with compulsive shopping habits frequently spend large sums of money over extended periods - sometimes exhausting their own financial resources.

While the situation can be stressful for family members, they should not turn a blind eye to the behavior or support the compulsive shopping by lending money. Psychologist Astrid Müller, a senior lecturer at the Psychosomatics and Psychotherapy Clinic of the Hannover Medical School, advises addressing the topic openly. Family members should remain understanding and respectful, avoiding accusations.

The goal is to motivate the affected person to seek help. Initial contact points can be therapy centers for addiction. To effectively combat the behavior, those affected need to explore the underlying need driving the shopping compulsion.

Written by urgent.news from Handelsblatt's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Read the original at handelsblatt.com →

More in Health & Medicine

Chong Kun Dang Signs KIO-301 Deal

Chong Kun Dang has joined hands with a US pharmaceutical company to treat a rare inherited retinal disease estimated to affect more than 10,000 patients in South Korea.Chong Kun Dang signed a…

  • Chong Kun Dang partners with Kiora Pharmaceuticals for KIO-301 development.
  • KIO-301 targets retinitis pigmentosa, affecting over 10,000 South Koreans.
  • Collaboration aims to expedite domestic clinical and approval processes.

More from Friday 21 August →